| Literature DB >> 32834622 |
Sarbjit Singh1,2, Kulwinder Singh Parmar3, Sidhu Jitendra Singh Makkhan4,5, Jatinder Kaur3,6, Shruti Peshoria7, Jatinder Kumar2.
Abstract
Discussions about the recently identified deadly coronavirus disease (COVID-19) which originated in Wuhan, China in December 2019 are common around the globe now. This is an infectious and even life-threatening disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has rapidly spread to other countries from its originating place infecting millions of people globally. To understand future phenomena, strong mathematical models are required with the least prediction errors. In the present study, autoregressive integrated moving average (ARIMA) and least square support vector machine (LS-SVM) models are applied to the data consisting of daily confirmed cases of SARS-CoV-2 in the most affected five countries of the world for modeling and predicting one-month confirmed cases of this disease. To validate these models, the prediction results were tested by comparing it with testing data. The results revealed better accuracy of the LS-SVM model over the ARIMA model and also suggested a rapid rise of SARS-CoV-2 confirmed cases in all the countries under study. This analysis would help governments to take necessary actions in advance associated with the preparation of isolation wards, availability of medicines and medical staff, a decision on lockdown, training of volunteers, and economic plans.Entities:
Keywords: ARIMA model; Least square support vector machine; Prediction; SARS-COV-2 cases
Year: 2020 PMID: 32834622 PMCID: PMC7345281 DOI: 10.1016/j.chaos.2020.110086
Source DB: PubMed Journal: Chaos Solitons Fractals ISSN: 0960-0779 Impact factor: 9.922
Fig. 1Time series plot of COVID-19 cases from Five countries.
Fig. 2Flow charts for modeling and forecasting of COVID-19 confirmed cases data using (a) ARIMA model (b) LS-SVM model.
Prediction performance of an ARIMA model.
| Country | MAE (x103) | MSE(x108) | RMSE(x103) | |
|---|---|---|---|---|
| Italy | 7.773 | 1.029 | 10.147 | 0.9817 |
| Spain | 29.322 | 14.246 | 37.744 | 0.7203 |
| France | 26.128 | 9.170 | 30.283 | 0.9627 |
| UK | 2.750 | 0.114 | 3.381 | 0.9990 |
| USA | 21.339 | 10.222 | 31.972 | 0.9963 |
Prediction performance of the LS-SVM model.
| Country | Training | Testing | ||||||
|---|---|---|---|---|---|---|---|---|
| MAE (x103) | MSE (x108) | RMSE (x103) | MAE (x103) | MSE (x108) | RMSE (x103) | |||
| Italy | 7.484 | 0.849 | 9.214 | 0.9788 | 4.616 | 0.337 | 6.114 | 0.9299 |
| Spain | 2.436 | 0.073 | 2.719 | 0.9988 | 5.790 | 0.515 | 7.176 | 0.8067 |
| France | 0.770 | 0.012 | 1.103 | 0.9992 | 12.180 | 1.680 | 12.965 | 0.9782 |
| UK | 0.705 | 0.006 | 0.782 | 0.9991 | 3.520 | 0.157 | 3.964 | 0.9966 |
| USA | 3.082 | 0.131 | 3.628 | 0.9997 | 18.405 | 5.137 | 22.667 | 0.9969 |
Fig. 3Comparison of ARIMA and LS-SVM models forecast of COVID-19 confirmed cases for the testing phase of the countries (i & ii) France (iii & iv) Italy (v & vi) Spain (vii & viii) UK and (ix & x) USA.
Fig. 4One month ahead of COVID-19 affected cases in different countries by the ARIMA model.